Table 3: Malignant tumors of the paranasal sinuses: Cranio-Nasal surgery and combined approach (Endonasal and External).
Age | Sex | Signs/symptoms | Location | Histology | Surgery | Adjuvant/Neoadjuvant treatment | Local control | Follow-up |
83 | M | Nasal obstruction | Ethmoid/facialskin/ skull base | MelanomaT4-a | Endoscopic + external approach | Radiotherapy | Not tumor | 1 year |
90 | F | Frontal tumor | Frontal sinus | Squamous cell carcinomaT4a | Endoscopic + external approach | Radiotherapy | Not tumor | 4 years |
58 | M | Nasal obstruction | Ethmoid | Esthesioneuroblastoma Kadish C | Cranio-nasal | Chemotherap/radiotherapy | Not tumor | 5 years |
49 | M | Nasal obstruction | Ethmoid | Undifferentiated carcinomaT4a | Cranio-nasal | Radiotherapy | Not tumor | 5 years |
45 | M | Cervical adenopathy | Bilateral ethmoid | Esthesioneuroblastoma Kadish C | Cranio-nasal | Chemotherap/radiotherapy | Not tumor | 4 years |
45 | M | Nasal obstruction | Ethmoid | Esthesioneuroblastoma Kadish C | Cranio-nasal | Chemotherap/radiotherapy | Not tumor | 9 years |
27 | F | Nasal obstruction | Ethmoid | Meduloblastoma | Cranio-nasal | Chemotherap/radiotherapy | Local persistence | 6 months |
61 | F | Frontal tumor | Frontal sinus | Undifferentiated carcinomaT4a | Cranio-nasal | Chemotherap/radiotherapy | Local persistence | 3 years |